Possible effects of the new Medicare reimbursement policy on African Americans with ESRD.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

1. An open-label, sequential, dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patients.BMC nephrology · 2012
   Trial
2. The economic considerations of patients and caregivers in choice of dialysis modality.Hemodialysis international. International Symposium on Home Hemodialysis · 2016
   Article
3. Comparative changes in treatment practices and clinical outcomes following implementation of a prospective payment system: the STEPPS study.BMC nephrology · 2015
   Article
4. Has dialysis payment reform led to initial racial disparities in anemia and mineral metabolism management?Journal of the American Society of Nephrology : JASN · 2015
   Article
5. Variation in dialysis quality measures by facility, neighborhood, and region.Medical care · 2013
   Article
6. Variant hemoglobin phenotypes may account for differential erythropoiesis-stimulating agent dosing in African-American hemodialysis patients.Kidney international · 2011
   Article
7. Meeting KDOQI guideline goals at hemodialysis initiation and survival during the first year.Clinical journal of the American Society of Nephrology : CJASN · 2010
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

8 authors at 3 institutions in 2 countries.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as